Diversity in Action: Workforce Case Studies
In this review of diversity in action, a panel will discuss lessons learned about the clinical trial workforce and what it means for diversity in clinical research. Panelists will share highlights and best practices from a case study and how it impacts all industry stakeholders.
Jaleeysa King, Business Analyst, Reporting & Analytics, Greenphire
Danielle Mitchell, Founder and CEO, Black Women in Clinical Research (BWICR)
Jeff Repper, Executive Vice President, Strategic Site Initiatives, TPS Global
Jamila Watkins, MBA, Associate Director, Patient Engagement and Solutions, Chinook Therapeutics
Hot Topic: Financial Implications of Diversity Strategy
This hot-topic panel discussion focuses on the financial implications of incorporating diversity into your organization’s strategy. We know that new diversity requirements will come with financial needs and changes at the site level, and this session will discuss what some of those changes are and how we ensure they are addressed.
David Vulcano, LCSW, MBA, CIP, RAC, VP Clinical Research Compliance & Integrity, HCA Healthcare, Honorary SCRS President
Van Johnson, VP of Business Development, Velocity Clinical
Kenny Nicholas , PhD, Chief Scientific Officer, Syneos Health
Fabian Sandoval, MD, President and CEO, Emerson Clinical Research Institute (ECRI)
Solutions Studio: Non-English Clinical Trial Nuances
This solution studio session will explore how to enable and support sites as they address the nuances of engaging non-English speaking patients in clinical trials. Understand what sites need to be successful in this area and how the industry can accommodate those needs for more inclusive trials.
Nicholas Focil, MBA, MS, CEO, Fomat Medical Research
Andres Rozo, CEO, IntegraIt
Hera Arham, MBA, MA, Director of Marketing & Patient Engagement, DM Clinical Research
Audrey Escobedo-Escotto, MD, MPH, Research Director, Emerson Clinical Research Institute
Marta Nelson, MSc, Director of Operations, MplusM Research Network
Hot Topic: The Unique Challenges Facing the LGBTQIA+ Community
This hot-topic panel will shed light on the multifaceted issues of unconscious biases that unfairly marginalize and exclude participants in clinical trials. The intention of this session will be to educate on what equity truly means for this diverse community by addressing existing antiquated practices and investigating ways to overcome these barriers with industry stakeholders.
Jessica Brescher, MPH, Sr. Clinical Scientist, Immunology and Fibrosis, Bristol Myers Squibb
Brandon Doyle, MBA, Associate Director, Site Alliances SME Global Site Diversity Strategy, Parexel
Garo Kiledjian, Chief Operating Officer, Trialogic